Treatment of bronchial asthma with disodium cromoglycate. Special indications.
Forty patients with various types of bronchial asthma were treated with disodium cromoglycate (DSCG) for various periods of time ranging from 30 days to 90 months. The drug was inhaled through a spinhaler at 8-hour intervals. The symptoms of asthma, the respiratory function and the drug-induced reactions were checked during treatment. DSCG was salutary in about 80% of the patients with extrinsic asthma (even in those with pollen allergy diagnosed within the pollination period). The drug was also effective in patients with exercise induced asthma, asthma associated with pregnancy, asthma with adrenocorticosteroid psychosis. The patients with meal allergy (bakers and millers) treated with DSCG were able to keep their occupational activities. The drug may be used in the intrinsic asthma only in subjects with many positive skin tests and hypereosinophilia.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D004205:Cromolyn Sodium